Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.
Biopharmaceutical company Celltrion has faced down the threat of a preliminary injunction of its biosmilar drug Omlyclo in an ...
The mainstay of therapy for the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) is Alexion's infusion therapy Soliris, but Novartis ... University in South Korea, the new trial's ...
Imexpharm offers a range of high-quality antibiotics, recognized for breakthroughs in purified raw material sourcing and ...
The new members are senior executives from the global leading pharmaceutical, biotech and technology industries and bring ...
The global anxiety disorders and depression treatment market, valued at approximately USD 11.2 billion in 2021, is on track ...
An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. The FDA has greenlighted Novartis’ Kisqali, used in ...
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce ...
Milan Jaros / Bloomberg via Getty Images Novartis said its Kisqali breast cancer drug produced longer success for those with certain forms of the disease. The drug maker reported Kisqali along ...
Novartis has partnered with Versant Ventures to establish Borealis Biosciences, a Canada-based independent, discovery-stage biotech company. The collaboration has resulted in $150m Series A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback